TY - JOUR AU - Bray, F. AU - Ferlay, J. AU - Soerjomataram, I. AU - Siegel, R. L. AU - Torre, L. A. AU - Jemal, A. PY - 2018 DA - 2018// TI - Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries JO - CA Cancer J Clin VL - 68 ID - Bray2018 ER - TY - JOUR AU - Banumathy, G. AU - Cairns, P. PY - 2010 DA - 2010// TI - Signaling pathways in renal cell carcinoma JO - Cancer Biol Ther VL - 10 UR - https://doi.org/10.4161/cbt.10.7.13247 DO - 10.4161/cbt.10.7.13247 ID - Banumathy2010 ER - TY - JOUR AU - Morais, C. PY - 2014 DA - 2014// TI - Sunitinib resistance in renal cell carcinoma JO - J kidney Cancer VHL VL - 1 UR - https://doi.org/10.15586/jkcvhl.2014.7 DO - 10.15586/jkcvhl.2014.7 ID - Morais2014 ER - TY - JOUR AU - Faivre, S. AU - Demetri, G. AU - Sargent, W. AU - Raymond, E. PY - 2007 DA - 2007// TI - Molecular basis for sunitinib efficacy and future clinical development JO - Nat Rev Drug Discov VL - 6 UR - https://doi.org/10.1038/nrd2380 DO - 10.1038/nrd2380 ID - Faivre2007 ER - TY - JOUR AU - Xin, H. AU - Zhang, C. AU - Herrmann, A. AU - Du, Y. AU - Figlin, R. AU - Yu, H. PY - 2009 DA - 2009// TI - Sunitinib inhibition of Stat3 induces renal cell carcinoma tumor cell apoptosis and reduces immunosuppressive cells JO - Cancer Res VL - 69 UR - https://doi.org/10.1158/0008-5472.CAN-08-4323 DO - 10.1158/0008-5472.CAN-08-4323 ID - Xin2009 ER - TY - JOUR AU - Huang, D. AU - Ding, Y. AU - Li, Y. AU - Luo, W. M. AU - Zhang, Z. F. AU - Snider, J. PY - 2010 DA - 2010// TI - Sunitinib acts primarily on tumor endothelium rather than tumor cells to inhibit the growth of renal cell carcinoma JO - Cancer Res VL - 70 UR - https://doi.org/10.1158/0008-5472.CAN-09-3722 DO - 10.1158/0008-5472.CAN-09-3722 ID - Huang2010 ER - TY - JOUR AU - Ko, J. J. AU - Xie, W. AU - Kroeger, N. AU - Lee, J. L. AU - Rini, B. I. AU - Knox, J. J. PY - 2015 DA - 2015// TI - The international metastatic renal cell carcinoma database consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based study JO - Lancet Oncol VL - 16 UR - https://doi.org/10.1016/S1470-2045(14)71222-7 DO - 10.1016/S1470-2045(14)71222-7 ID - Ko2015 ER - TY - JOUR AU - Tourneau, C. AU - Raymond, E. AU - Faivre, S. PY - 2007 DA - 2007// TI - Sunitinib: a novel tyrosine kinase inhibitor. A brief review of its therapeutic potential in the treatment of renal carcinoma and gastrointestinal stromal tumors (GIST) JO - Ther Clin Risk Manag VL - 3 UR - https://doi.org/10.2147/tcrm.2007.3.2.341 DO - 10.2147/tcrm.2007.3.2.341 ID - Tourneau2007 ER - TY - JOUR AU - Goldberg, S. B. AU - Oxnard, G. R. AU - Digumarthy, S. AU - Muzikansky, A. AU - Jackman, D. M. AU - Lennes, I. T. PY - 2013 DA - 2013// TI - Chemotherapy with Erlotinib or chemotherapy alone in advanced non-small cell lung cancer with acquired resistance to EGFR tyrosine kinase inhibitors JO - Oncologist VL - 18 UR - https://doi.org/10.1634/theoncologist.2013-0168 DO - 10.1634/theoncologist.2013-0168 ID - Goldberg2013 ER - TY - JOUR AU - Mastri, M. AU - Tracz, A. AU - Lee, C. R. AU - Dolan, M. AU - Attwood, K. AU - Christensen, J. G. PY - 2018 DA - 2018// TI - A transient Pseudosenescent Secretome promotes tumor growth after Antiangiogenic therapy withdrawal JO - Cell Rep VL - 25 UR - https://doi.org/10.1016/j.celrep.2018.12.017 DO - 10.1016/j.celrep.2018.12.017 ID - Mastri2018 ER - TY - JOUR AU - Unkruer, B. AU - Pekcec, A. AU - Fuest, C. AU - Wehmeyer, A. AU - Balda, M. S. AU - Horn, A. PY - 2009 DA - 2009// TI - Cellular localization of Y-box binding protein 1 in brain tissue of rats, macaques, and humans JO - BMC Neurosci VL - 10 UR - https://doi.org/10.1186/1471-2202-10-28 DO - 10.1186/1471-2202-10-28 ID - Unkruer2009 ER - TY - JOUR AU - Wu, J. AU - Stratford, A. L. AU - Astanehe, A. AU - Dunn, S. E. PY - 2007 DA - 2007// TI - YB-1 is a transcription/translation factor that orchestrates the Oncogenome by hardwiring signal transduction to gene expression JO - Transl Oncogenomics VL - 2 ID - Wu2007 ER - TY - JOUR AU - Lyabin, D. N. AU - Eliseeva, I. A. AU - Ovchinnikov, L. P. PY - 2014 DA - 2014// TI - YB-1 protein: functions and regulation JO - Wiley Interdiscip Rev RNA VL - 5 UR - https://doi.org/10.1002/wrna.1200 DO - 10.1002/wrna.1200 ID - Lyabin2014 ER - TY - JOUR AU - Wang, Y. AU - Chen, Y. AU - Geng, H. AU - Qi, C. AU - Liu, Y. AU - Yue, D. PY - 2015 DA - 2015// TI - Overexpression of YB1 and EZH2 are associated with cancer metastasis and poor prognosis in renal cell carcinomas JO - Tumour biol VL - 36 UR - https://doi.org/10.1007/s13277-015-3417-z DO - 10.1007/s13277-015-3417-z ID - Wang2015 ER - TY - JOUR AU - Wang, Y. AU - Yue, D. AU - Xiao, M. AU - Qi, C. AU - Chen, Y. AU - Sun, D. PY - 2015 DA - 2015// TI - C1QBP negatively regulates the activation of oncoprotein YBX1 in the renal cell carcinoma as revealed by interactomics analysis JO - J Proteome Res VL - 14 UR - https://doi.org/10.1021/pr500847p DO - 10.1021/pr500847p ID - Wang2015 ER - TY - JOUR AU - Frye, B. C. AU - Halfter, S. AU - Djudjaj, S. AU - Muehlenberg, P. AU - Weber, S. AU - Raffetseder, U. PY - 2009 DA - 2009// TI - Y-box protein-1 is actively secreted through a non-classical pathway and acts as an extracellular mitogen JO - EMBO Rep VL - 10 UR - https://doi.org/10.1038/embor.2009.81 DO - 10.1038/embor.2009.81 ID - Frye2009 ER - TY - JOUR AU - Havel, J. J. AU - Chowell, D. AU - Chan, T. A. PY - 2019 DA - 2019// TI - The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy JO - Nat Rev Cancer VL - 19 UR - https://doi.org/10.1038/s41568-019-0116-x DO - 10.1038/s41568-019-0116-x ID - Havel2019 ER - TY - JOUR AU - Hellmann, M. D. AU - Ciuleanu, T. E. AU - Pluzanski, A. AU - Lee, J. S. AU - Otterson, G. A. AU - Audigier-Valette, C. PY - 2018 DA - 2018// TI - Nivolumab plus Ipilimumab in lung Cancer with a high tumor mutational burden JO - N Engl J Med VL - 378 UR - https://doi.org/10.1056/NEJMoa1801946 DO - 10.1056/NEJMoa1801946 ID - Hellmann2018 ER - TY - JOUR AU - Hakimi, A. A. AU - Voss, M. H. AU - Kuo, F. AU - Sanchez, A. AU - Liu, M. AU - Nixon, B. G. PY - 2019 DA - 2019// TI - Transcriptomic profiling of the tumor microenvironment reveals distinct subgroups of clear cell renal cell Cancer: data from a randomized phase III trial JO - Cancer Discov VL - 9 UR - https://doi.org/10.1158/2159-8290.CD-18-0957 DO - 10.1158/2159-8290.CD-18-0957 ID - Hakimi2019 ER - TY - JOUR AU - Ambudkar, S. V. AU - Sauna, Z. E. AU - Gottesman, M. M. AU - Szakacs, G. PY - 2005 DA - 2005// TI - A novel way to spread drug resistance in tumor cells: functional intercellular transfer of P-glycoprotein (ABCB1) JO - Trends Pharmacol Sci VL - 26 UR - https://doi.org/10.1016/j.tips.2005.06.001 DO - 10.1016/j.tips.2005.06.001 ID - Ambudkar2005 ER - TY - JOUR AU - Fletcher, J. I. AU - Haber, M. AU - Henderson, M. J. AU - Norris, M. D. PY - 2010 DA - 2010// TI - ABC transporters in cancer: more than just drug efflux pumps JO - Nat Rev Cancer VL - 10 UR - https://doi.org/10.1038/nrc2789 DO - 10.1038/nrc2789 ID - Fletcher2010 ER - TY - JOUR AU - Sugano, T. AU - Seike, M. AU - Noro, R. AU - Soeno, C. AU - Chiba, M. AU - Zou, F. PY - 2015 DA - 2015// TI - Inhibition of ABCB1 overcomes Cancer stem cell-like properties and acquired resistance to MET inhibitors in non-small cell lung Cancer JO - Mol Cancer Ther VL - 14 UR - https://doi.org/10.1158/1535-7163.MCT-15-0050 DO - 10.1158/1535-7163.MCT-15-0050 ID - Sugano2015 ER - TY - JOUR AU - Lagas, J. S. AU - Waterschoot, R. A. B. AU - Tilburg, V. A. C. J. AU - Hillebrand, M. J. AU - Lankheet, N. AU - Rosing, H. PY - 2009 DA - 2009// TI - Brain accumulation of Dasatinib is restricted by P-glycoprotein (ABCB1) and breast Cancer resistance protein (ABCG2) and can be enhanced by Elacridar treatment JO - Clin Cancer Res VL - 15 UR - https://doi.org/10.1158/1078-0432.CCR-08-2253 DO - 10.1158/1078-0432.CCR-08-2253 ID - Lagas2009 ER - TY - JOUR AU - Han, K. S. AU - Raven, P. A. AU - Frees, S. AU - Gust, K. AU - Fazli, L. AU - Ettinger, S. PY - 2015 DA - 2015// TI - Cellular adaptation to VEGF-targeted Antiangiogenic therapy induces evasive resistance by overproduction of alternative endothelial cell growth factors in renal cell carcinoma JO - Neoplasia. VL - 17 UR - https://doi.org/10.1016/j.neo.2015.11.001 DO - 10.1016/j.neo.2015.11.001 ID - Han2015 ER - TY - JOUR AU - Raven, P. e. t. e. r. A. AU - Lysakowski, S. u. m. m. e. r. AU - Tan, Z. h. e. n. g. AU - D'Costa, N. i. n. a. d. h. M. AU - Moskalev, I. g. o. r. AU - Frees, S. e. b. a. s. t. i. a. n. AU - Struss, W. e. r. n. e. r. AU - Matsui, Y. o. s. h. i. y. u. k. i. AU - Narita, S. h. i. n. t. a. r. o. AU - Buttyan, R. a. l. p. h. AU - Chavez‐Munoz, C. l. a. u. d. i. a. AU - So, A. l. a. n. I. PY - 2019 DA - 2019// TI - Inhibition of GLI2 with antisense‐oligonucleotides: A potential therapy for the treatment of bladder cancer JO - Journal of Cellular Physiology VL - 234 UR - https://doi.org/10.1002/jcp.28669 DO - 10.1002/jcp.28669 ID - Raven2019 ER - TY - JOUR AU - Frees, S. AU - Zhou, B. AU - Han, K. S. AU - Tan, Z. AU - Raven, P. AU - Wong, A. PY - 2018 DA - 2018// TI - The role of netrin-1 in metastatic renal cell carcinoma treated with sunitinib JO - Oncotarget. VL - 9 UR - https://doi.org/10.18632/oncotarget.25201 DO - 10.18632/oncotarget.25201 ID - Frees2018 ER - TY - JOUR AU - Hughes, C. S. AU - Spicer, V. AU - Krokhin, O. V. AU - Morin, G. B. PY - 2017 DA - 2017// TI - Investigating acquisition performance on the Orbitrap fusion when using tandem MS/MS/MS scanning with isobaric tags JO - J Proteome Res VL - 16 UR - https://doi.org/10.1021/acs.jproteome.7b00091 DO - 10.1021/acs.jproteome.7b00091 ID - Hughes2017 ER - TY - STD TI - Escudier B, Motzer RJ, Tannir NM, Porta C, Tomita Y, Maurer MA, McHenry MB, Rini BI. Efficay of Nivolumab plus Ipilimumab according to number of IMDC risk factors in CheckMate 214. Eur Urol. 2019;(19):30824–3. https://doi.org/10.1016/j.eururo.2019.10.025. [Epub ahead of print]. PMID: 31732098. ID - ref28 ER - TY - JOUR AU - Gourd, K. PY - 2017 DA - 2017// TI - CheckMate 214 trial JO - Lancet Oncology VL - 18 UR - https://doi.org/10.1016/S1470-2045(17)30713-1 DO - 10.1016/S1470-2045(17)30713-1 ID - Gourd2017 ER - TY - JOUR AU - Evdokimova, V. AU - Ruzanov, P. AU - Anglesio, M. S. AU - Sorokin, A. V. AU - Ovchinnikov, L. P. AU - Buckley, J. PY - 2006 DA - 2006// TI - Akt-mediated YB-1 phosphorylation activates translation of silent mRNA species JO - Mol Cell Biol VL - 26 UR - https://doi.org/10.1128/MCB.26.1.277-292.2006 DO - 10.1128/MCB.26.1.277-292.2006 ID - Evdokimova2006 ER - TY - JOUR AU - Shiota, M. AU - Yokomizo, A. AU - Takeuchi, A. AU - Itsumi, M. AU - Imada, K. AU - Kashiwagi, E. PY - 2014 DA - 2014// TI - Inhibition of RSK/YB-1 signaling enhances the anti-cancer effect of enzalutamide in prostate cancer JO - Prostate VL - 74 UR - https://doi.org/10.1002/pros.22813 DO - 10.1002/pros.22813 ID - Shiota2014 ER - TY - JOUR AU - Hsieh, A. C. AU - Liu, Y. AU - Edlind, M. P. AU - Ingolia, N. T. AU - Janes, M. R. AU - Sher, A. PY - 2012 DA - 2012// TI - The translational landscape of mTOR signalling steers cancer initiation and metastasis JO - Nature VL - 485 UR - https://doi.org/10.1038/nature10912 DO - 10.1038/nature10912 ID - Hsieh2012 ER - TY - JOUR AU - Lyabin, D. m. i. t. r. y. N. AU - Eliseeva, I. r. i. n. a. A. AU - Ovchinnikov, L. e. v. P. PY - 2012 DA - 2012// TI - YB-1 Synthesis Is Regulated by mTOR Signaling Pathway JO - PLoS ONE VL - 7 UR - https://doi.org/10.1371/journal.pone.0052527 DO - 10.1371/journal.pone.0052527 ID - Lyabin2012 ER - TY - JOUR AU - Motzer, R. J. AU - Escudier, B. AU - Oudard, S. AU - Hutson, T. E. AU - Porta, C. AU - Bracarda, S. PY - 2008 DA - 2008// TI - Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial JO - Lancet VL - 372 UR - https://doi.org/10.1016/S0140-6736(08)61039-9 DO - 10.1016/S0140-6736(08)61039-9 ID - Motzer2008 ER - TY - JOUR AU - Kornakiewicz, A. AU - Solarek, W. AU - Bielecka, Z. F. AU - Lian, F. AU - Szczylik, C. AU - Czarnecka, A. M. PY - 2014 DA - 2014// TI - Mammalian target of Rapamycin inhibitors resistance mechanisms in clear cell renal cell carcinoma JO - Curr Signal Transduct Ther VL - 8 UR - https://doi.org/10.2174/1574362409666140206222746 DO - 10.2174/1574362409666140206222746 ID - Kornakiewicz2014 ER - TY - STD TI - Saadia A Aziz, Joshua Sznol, Adebowale Adeniran, John W Colberg, Robert L Camp, and Harriet M Kluger. Vascularity of primary and metastatic renal cell carcinoma specimens. J Transl Med. 2013;11:15. ID - ref36 ER - TY - JOUR AU - Brodaczewska, K. K. AU - Szczylik, C. AU - Fiedorowicz, M. AU - Porta, C. AU - Czarnecka, A. M. PY - 2016 DA - 2016// TI - Choosing the right cell line for renal cell cancer research JO - Mol Cancer VL - 15 UR - https://doi.org/10.1186/s12943-016-0565-8 DO - 10.1186/s12943-016-0565-8 ID - Brodaczewska2016 ER - TY - JOUR AU - Eliseeva, I. A. AU - Kim, E. R. AU - Guryanov, S. G. AU - Ovchinnikov, L. P. AU - Lyabin, D. N. PY - 2011 DA - 2011// TI - Y-box-binding protein 1 (YB-1) and its functions JO - Biochemistry Biokhimiia VL - 76 UR - https://doi.org/10.1134/S0006297911130049 DO - 10.1134/S0006297911130049 ID - Eliseeva2011 ER - TY - JOUR AU - Wang, Y. AU - Su, J. AU - Wang, Y. AU - Fu, D. AU - Ideozu, J. E. AU - Geng, H. PY - 2019 DA - 2019// TI - The interaction of YBX1 with G3BP1 promotes renal cell carcinoma cell metastasis via YBX1/G3BP1-SPP1- NF-kappaB signaling axis JO - J Exp Clin Cancer Res VL - 38 UR - https://doi.org/10.1186/s13046-019-1347-0 DO - 10.1186/s13046-019-1347-0 ID - Wang2019 ER - TY - JOUR AU - Motzer, R. J. AU - Barrios, C. H. AU - Kim, T. M. AU - Falcon, S. AU - Cosgriff, T. AU - Harker, W. G. PY - 2014 DA - 2014// TI - Phase II randomized trial comparing sequential first-line everolimus and second-line sunitinib versus first-line sunitinib and second-line everolimus in patients with metastatic renal cell carcinoma JO - J Clin Oncol VL - 32 UR - https://doi.org/10.1200/JCO.2013.54.6911 DO - 10.1200/JCO.2013.54.6911 ID - Motzer2014 ER - TY - JOUR AU - Molina, A. M. AU - Feldman, D. R. AU - Voss, M. H. AU - Ginsberg, M. S. AU - Baum, M. S. AU - Brocks, D. R. PY - 2012 DA - 2012// TI - Phase 1 trial of everolimus plus sunitinib in patients with metastatic renal cell carcinoma JO - Cancer VL - 118 UR - https://doi.org/10.1002/cncr.26429 DO - 10.1002/cncr.26429 ID - Molina2012 ER - TY - JOUR AU - Tellingen, O. AU - Yetkin-Arik, B. AU - Gooijer, M. C. AU - Wesseling, P. AU - Wurdinger, T. AU - Vries, H. E. PY - 2015 DA - 2015// TI - Overcoming the blood-brain tumor barrier for effective glioblastoma treatment JO - Drug Resist Updat VL - 19 UR - https://doi.org/10.1016/j.drup.2015.02.002 DO - 10.1016/j.drup.2015.02.002 ID - Tellingen2015 ER - TY - JOUR AU - Giuliano, S. AU - Cormerais, Y. AU - Dufies, M. AU - Grepin, R. AU - Colosetti, P. AU - Belaid, A. PY - 2015 DA - 2015// TI - Resistance to sunitinib in renal clear cell carcinoma results from sequestration in lysosomes and inhibition of the autophagic flux JO - Autophagy VL - 11 UR - https://doi.org/10.1080/15548627.2015.1085742 DO - 10.1080/15548627.2015.1085742 ID - Giuliano2015 ER -